Clinical trials
Other Cancer clinical trials
Below are recruiting other cancer clinical trials, each written for real people, not researchers. We’re tracking 13,040 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07016724RecruitingPhase 2
Study of radiation and chemo with cadonilizumab for esophageal cancer
This trial tests combining radiation, chemotherapy, and the drug cadonilizumab before surgery for locally advanced esophageal squamous cell cancer. It aims to shrink the tumor and improve treatment outcomes.
Zhengzhou, HenanAges 18–75 - NCT07016997RecruitingPhase 1
A study of CBA-1535 for advanced solid tumors
This trial tests a new drug, CBA-1535, which is designed to help your immune system attack cancer cells. It is for people with advanced solid tumors who have run out of standard treatment options or cannot tolerate them.
Nagaizumicho, ShizuokaAges 20 years+ - NCT07018037Recruiting
TTV levels during first immunotherapy for kidney cancer
This study looks at whether a virus called TTV (torque teno virus) in the blood can help predict how well immunotherapy works for advanced kidney cancer. If you have clear cell renal cell carcinoma that has spread and are about to start your first immunotherapy, you may be able to join.
Rome, RomeAges 18 years+ - NCT07018570RecruitingPhase 2
Chemo, immunotherapy, and radiation for stomach cancer before surgery
This trial tests a combination of chemotherapy (FLOT), an immunotherapy drug (pembrolizumab), and short-course radiation before surgery for gastroesophageal junction cancer. The goal is to see if this approach improves outcomes.
Kashiwa, ChibaAges 18 years+ - NCT07019675RecruitingPhase 2
Study of a new drug for people with lung cancer
This trial tests a new medication, SKB518, for people with non-small cell or small cell lung cancer who have at least one measurable tumor and are in fairly good health. It aims to see if the drug can help shrink tumors or slow the cancer's growth.
Shenzhen, GuangdongAges 18–75 - NCT07020169Recruiting
Using AI 3D kidney models to guide partial nephrectomy
This trial tests if a 3D kidney model made with artificial intelligence helps surgeons remove a kidney tumor (partial nephrectomy) more precisely. It may help preserve healthy kidney tissue while treating the cancer.
Nanjing, JiangsuAges 18–80 - NCT07019870Recruiting
Screening for early diagnosis of nose cancer
This trial offers free screening to find nose cancer (nasopharyngeal carcinoma or NPC) early, before symptoms start. It is for people with a family history of NPC who may be at higher risk.
SingaporeAges 35–60 - NCT07020806RecruitingPhase 1
New imaging test for invasive lobular breast cancer that has spread
This trial tests a new imaging agent, [68Ga]Ga DOTA-5G, to see if it can better detect invasive lobular breast cancer that has spread to other parts of the body. It involves a PET/CT scan and may help doctors understand the extent of your cancer.
Sacramento, CaliforniaAges 18–89 - NCT07021196Recruiting
Home exercise program for breast or prostate cancer patients
This study tests a home-based exercise program designed just for you, tailored using a smartphone or tablet. It aims to help people with breast or prostate cancer get stronger and feel better after surgery.
NaplesAges 18–80 - NCT07021885Recruiting
Nutrition literacy and outcomes in head and neck cancer survivors and caregivers
This study looks at how nutrition literacy (understanding food and diet) affects health outcomes for head and neck cancer survivors and their caregivers. If you are a survivor who finished treatment 6 months to 4 years ago and can eat by mouth, you and your caregiver may be able to join.
Kansas City, KansasAges 18 years+ - NCT07022470RecruitingPhase 2
Comparing 3 vs. 4 brachytherapy sessions for cervical cancer
This trial compares two different schedules of brachytherapy (a type of internal radiation) for cervical cancer. It aims to see if a shorter course of 3 treatments works just as well as the standard 4 treatments, which could mean fewer visits and less discomfort.
Palo Alto, CaliforniaAges 18 years+ - NCT07023432RecruitingPhase 2
Belzutifan vs. watchful waiting for slow-growing kidney cancer
This trial compares two approaches for people with slow-growing, metastatic clear cell kidney cancer: taking a daily pill (belzutifan) or monitoring the cancer closely without treatment. The goal is to see if starting treatment early can help control the cancer longer than waiting.
Houston, TexasAges 18 years+ - NCT07024329Recruiting
Remote symptom tracking for cancer patients
This study tests a system where you report your symptoms online or by phone from home. A nurse will call you to help manage any side effects of your treatment.
Calgary, AlbertaAges 18 years+ - NCT07026149RecruitingPhase 2
Combination therapy before surgery for stomach cancer
This trial tests a combination of radiation, chemotherapy (SOX), and two targeted drugs (apatinib and camrelizumab) before and after surgery for stomach or gastroesophageal junction cancer. It aims to see if this approach is safe and effective.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07027280Recruiting
Measuring Tumor Differences in Head and Neck Cancer
This study uses scans and tissue samples to look at differences within your tumor (called heterogeneity). It may help doctors understand your cancer better and choose the best treatment approach.
ChongqingAges 15–89 - NCT07029217RecruitingPhase 3
Lower radiation dose study for B-cell lymphomas
This study tests if a reduced dose of radiation therapy works well for certain types of B-cell lymphomas, specifically follicular lymphoma and marginal zone lymphoma. It aims to minimize side effects while still controlling the disease.
Basking Ridge, New JerseyAges 18 years+ - NCT07029490Recruiting
Study to improve mammogram outreach for underserved groups
This trial tests a program to help people who face barriers get routine mammograms. If you are going for a regular breast cancer screening, you may be able to join.
Salt Lake City, UtahAges 18 years+ - NCT07030140RecruitingPhase 2
Immunotherapy, radiation and chemo for bile duct cancer
This trial tests a new combination of immunotherapy (tislelizumab), radiation, and chemotherapy before surgery for people with bile duct cancer that is hard to remove. The goal is to shrink the tumor enough to allow successful surgery.
Jinan, ShandongAges 18–75 - NCT07030400Recruiting
Quality of life study for adults with CLL or SLL
This study looks at how health-related quality of life changes in people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) when starting a new treatment. The goal is to better understand what affects well-being during therapy.
Tampa, FloridaAges 18 years+ - NCT07030998Recruiting
Using smartwatch data to find early signs of infection in kids with cancer
This trial uses an Apple Watch and a smartphone app to track health data and detect early signs of infection in children and teens getting cancer treatment. The goal is to catch problems early so they can be treated quickly.
Parkville, VictoriaAges 5–18 - NCT07032961Recruiting
Capsule camera screening for stomach issues
This study is testing a new, less invasive way to screen for stomach problems using a tiny capsule that you swallow. It's for older adults or those at higher risk of stomach cancer who live in Guangzhou.
Guangzhou, GuangdongAges 45 years+ - NCT07033689RecruitingEarly Phase 1
Testing Suizenji for newly diagnosed pancreatic cancer
This trial tests a new ultrasound treatment called Suizenji for people with pancreatic cancer that cannot be removed by surgery. The goal is to see if it can safely target the tumor.
San Francisco, CaliforniaAges 18 years+ - NCT07035418Recruiting
Young adults' role in cancer care decisions
This study looks at how much young people with cancer (ages 15–29) want to be involved in making decisions about their care. It's for those currently on treatment, at end of life, or who finished treatment up to a year ago.
Palo Alto, CaliforniaAges 15–29 - NCT07035587Recruiting
A blood test to detect multiple cancers and monitor leftover tumors after treatment
This trial uses a blood test to find early signs of cancer or leftover tumor cells after treatment. It may help people with certain cancers or those with non-cancerous growths understand their condition better.
SeoulAges 19 years+
Hear when a new Other Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for other cancer?
- Yes. Clin2 currently lists 13,040 recruiting other cancer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a other cancer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a other cancer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.